Mini Review
Published on 16 Feb 2021
Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2020.593848
- 14,063 views
- 36 citations
